Healthcare Services

Hidradenitis Suppurativa Market Forecast to 2030: Trends and Developments

April 22, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Hidradenitis Suppurativa Market From 2026 To 2030?

The size of the hidradenitis suppurativa market has shown robust growth in recent years. Projections indicate it will expand from $1.24 billion in 2025 to $1.33 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.8%. This expansion over the historical period stems from factors such as the growing occurrence of chronic inflammatory skin disorders, enhanced dermatology diagnostic capabilities, increased awareness of HS symptoms, the proliferation of dermatology clinics, and the availability of antibiotic treatment alternatives.

The hidradenitis suppurativa market is projected to experience substantial expansion in the coming years. It is anticipated to reach a valuation of $1.75 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This projected increase during the forecast period is fueled by several factors, including an escalating demand for targeted biologic medications, a heightened emphasis on sustained disease management, the proliferation of personalized dermatological services, the increasing uptake of advanced laser treatments, and greater investment in research for chronic skin conditions. Key developments expected within this period encompass the wider embrace of biologic therapies for HS, an uptick in the utilization of minimally invasive surgical interventions, a stronger emphasis on prompt disease identification, the broader application of combined treatment strategies, and the improvement of patient-focused care models.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/hidradenitis-suppurativa-global-market-report

What Key Factors Are Affecting The Hidradenitis Suppurativa Market Demand?

An increasing incidence of skin conditions is propelling the expansion of the hidradenitis suppurativa market into the future. These dermatological ailments encompass a broad spectrum of issues, such as those stemming from bacterial, viral, or fungal infections, allergic reactions, skin cancers, and parasitic infestations. Hidradenitis suppurativa (HS), being a chronic and severe dermatological condition, is spurring the creation of innovative products and services for its treatment, driven by heightened public awareness, improved diagnostic accuracy, an expanding patient population, and progress in research. As an illustration, the American Cancer Society, a US-based non-profit organization focused on eradicating cancer, projected 108,270 reported skin cancer cases in January 2024, representing a 3.2% rise from the 104,930 cases documented in 2023. Consequently, the expanding occurrence of skin ailments fuels the development of the hidradenitis suppurativa market.

How Is The Hidradenitis Suppurativa Market Broken Down By Segment Categories?

The hidradenitis suppurativa market covered in this report is segmented –

1) By Disease Severity: Hurley Stage I, Hurley Stage II, Hurley Stage III

2) By Treatment: Medications, Surgical Treatment

3) By Route of Administration: Oral, Subcutaneous, Topical

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Specialty Pharmacies

5) By End User: Hospitals, Dermatology Clinics Or Specialty Clinics, Ambulatory Surgical Centers

Subsegments:

1) By Medications: Antibiotics, Biologics, Hormonal Therapy, Immunosuppressants, Retinoids

2) By Surgical Treatment: Incision and Drainage, Deroofing, Wide Excision, Laser & Light-Based Therapy

What Trends Are Influencing Changes In The Hidradenitis Suppurativa Market?

Leading companies within the hidradenitis suppurativa market are dedicating efforts to developing advanced biologic treatments aimed at enhancing patient outcomes and addressing current medical needs. Biologics are medicines derived from living organisms that specifically target components of the immune system involved in the progression of the disease. For instance, in June 2023, Novartis AG, a pharmaceutical company headquartered in Switzerland, obtained European regulatory approval for Cosentyx for hidradenitis suppurativa. Cosentyx is the inaugural and sole fully human biologic that specifically inhibits interleukin-17A, a crucial cytokine linked to hidradenitis suppurativa. Supported by over 14 years of clinical research, Cosentyx offers an established and targeted therapeutic solution, solidifying Novartis’s presence in the hidradenitis suppurativa market.

Which Players Are Present In The Hidradenitis Suppurativa Market Space?

Major companies operating in the hidradenitis suppurativa market are AbbVie Inc., Pfizer Inc., Johnson & Johnson, Novartis AG, Eli Lilly and Company, UCB S.A., LEO Pharma A/S, Almirall S.A., AstraZeneca plc, Bayer AG, Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Ltd., Taro Pharmaceutical Industries Ltd., AnaptysBio Inc., Acelyrin Inc., Arcutis Biotherapeutics Inc., Priovant Therapeutics, Aristea Therapeutics, Union Therapeutics, Revance Therapeutics

Get The Full Hidradenitis Suppurativa Market Report:

https://www.thebusinessresearchcompany.com/report/hidradenitis-suppurativa-global-market-report

Where Is The Hidradenitis Suppurativa Market Primarily Concentrated By Region?

North America was the largest region in the hidradenitis suppurativa market in 2025. The regions covered in the hidradenitis suppurativa market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Hidradenitis Suppurativa Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/hidradenitis-suppurativa-global-market-report

Browse Through More Reports Similar to the Global Hidradenitis Suppurativa Market 2026, By The Business Research Company

Chronic Spontaneous Urticaria Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-spontaneous-urticaria-global-market-report

Dermatitis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/dermatitis-drugs-global-market-report

Seborrheic Dermatitis Market Report 2026

https://www.thebusinessresearchcompany.com/report/seborrheic-dermatitis-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795